SCHEMBL26470002

SCHEMBL26470002

CCC(NC(=O)c1cn(C(C)C)nc1-c1ccccc1F)c1cccc(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DCAF1 Q9Y4B6 4/20 0.52
CTSA P10619 1/20 0.49
MAPK1 P28482 13/20 0.46
TACR3 P29371 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26795041 0.90 DCAF1 (0.66) DCAF1CTSAMAPK1
SCHEMBL27369855 0.76 DCAF1 (0.50) DCAF1CTSAMAPK1TACR3
SCHEMBL28076662 0.72 ALDH1A1 (0.56) DCAF1CTSAMAPK1
SCHEMBL19025632 0.72 ALDH1A1 (0.56) DCAF1CTSAMAPK1
SCHEMBL26795044 0.71 DCAF1 (0.65) DCAF1CTSAMAPK1
SCHEMBL21854037 0.71 NPC1 (0.42)
SCHEMBL25077793 0.71 CTSA (0.49) DCAF1CTSAMAPK1
SCHEMBL27369820 0.69 DCAF1 (0.63) DCAF1CTSAMAPK1
SCHEMBL14338398 0.68 TAS1R3 (0.52) MAPK1
SCHEMBL27278324 0.67 DCAF1 (0.63) DCAF1CTSAMAPK1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092011-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed